Betamethasone Valerate EP Impurity G(en-17) Betamethasone Valerate EP Impurity G
-
Betamethasone Valerate EP Impurity C(en-17) Betamethasone Valerate EP Impurity C
B-065027 | 100mg
-
Betamethasone Valerate EP Impurity D(en-17) Betamethasone Valerate EP Impurity D
B-065023 | 100mg
-
Betamethasone Valerate EP Impurity F(en-17) Betamethasone Valerate EP Impurity F
B-065028 | 100mg
-
Betamethasone Valerate EP Impurity H(en-17) Betamethasone Valerate EP Impurity H
B-065011 | 100mg
-
Betamethasone Valerate EP Impurity I(en-17) Betamethasone Valerate EP Impurity I
B-065033 | 100mg
-
Betamethasone Valerate EP Impurity E (Betamethasone Valerate USP Related Compound A, Betamethasone 21-Valerate)(en-17) Betamethasone Valerate EP Impurity E (Betamethasone Valerate USP Related Compound A, Betamethasone 21-Valerate)
B-065012 | 100mg
-
Betamethasone EP Impurity G(en-3) Betamethasone EP Impurity G
B-065018 | 100mg
化合物名称:Betamethasone Valerate EP Impurity G
同义词:(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-bromo-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate
CAS 号:
其他 CAS 号:
分子式:C27H36BrFO6
分子量:/
结构式图片:
您正在浏览的产品:Betamethasone Valerate EP Impurity G
本公司销售的所有产品仅供实验科研使用,不用于人体及临床诊断。
2. 色谱条件优化:平衡色谱柱至基线稳定;
3. 系统适用性测试:理论塔板数≥5000。
2. 方法学验证:包括精密度、线性及稳定性。
以上信息仅供参考,请以相应标准的原文为准!